ATXI
Avenue Therapeutics, Inc. Common Stock
ATXI
ATXI
Delisted
ATXI was delisted on the 18th of March, 2025.
17 hedge funds and large institutions have $1.62M invested in Avenue Therapeutics, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
17
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$88.9K | |
| 2 | +$72.3K | |
| 3 | +$49.6K | |
| 4 |
KAS
Kestra Advisory Services
Austin,
Texas
|
+$41.3K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$10.3K |
Top Sellers
| 1 | -$88K | |
| 2 | -$76K | |
| 3 | -$68.2K | |
| 4 |
VF
Virtu Financial
New York
|
-$66K |
| 5 |
Goldman Sachs
New York
|
-$58K |